The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation represents a good response to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage non-small cell lung cancer (NSCLC). However, the predictive value of EGFR mutation for prognosis in NSCLC patients after c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Transl Lung Cancer Res
Huvudupphovsmän: He, Qihua, Xin, Peiling, Zhang, Mingzhe, Jiang, Si, Zhang, Jianrong, Zhong, Shengyi, Liu, Yang, Guo, Minzhang, Chen, Xuewei, Xia, Xiaojun, Pan, Zhenkui, Guo, Chenye, Cai, Xiuyu, Liang, Wenhua, He, Jianxing
Materialtyp: Artigo
Språk:Inglês
Publicerad: AME Publishing Company 2019
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6504652/
https://ncbi.nlm.nih.gov/pubmed/31106123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.03.14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk